MedPath

Ness, Gregory M DDS

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Correction of Farsightedness in Children Study

Not Applicable
Completed
Conditions
Farsightedness
Hyperopia
Interventions
Device: Control
Device: Spectacles
First Posted Date
2007-05-11
Last Posted Date
2023-04-18
Lead Sponsor
Ohio State University
Target Recruit Count
58
Registration Number
NCT00472212
Locations
🇺🇸

Illinois College of Optometry/Illinois Eye Institute, Chicago, Illinois, United States

🇺🇸

SUNY College of Optometry/University Optometric Center, New York, New York, United States

🇺🇸

The Ohio State University, Columbus, Ohio, United States

and more 1 locations

Study of Eyes and Attention Deficit (SEAD)

Completed
Conditions
ADHD
Convergence Insufficiency
Accommodative Insufficiency
First Posted Date
2007-05-11
Last Posted Date
2008-07-03
Lead Sponsor
Ohio State University
Target Recruit Count
75
Registration Number
NCT00472511

Study of Eye Movement Testing and Therapy

Not Applicable
Completed
Conditions
Saccadic Eye Movement Deficiency
Oculomotor Deficiency
Oculomotor Dysfunction
First Posted Date
2007-05-11
Last Posted Date
2008-07-03
Lead Sponsor
Ohio State University
Target Recruit Count
40
Registration Number
NCT00472485
Locations
🇺🇸

The Ohio State University, Columbus, Ohio, United States

Cycloplegic Delivery Investigation

Not Applicable
Completed
Conditions
Healthy
First Posted Date
2007-05-11
Last Posted Date
2008-07-03
Lead Sponsor
Ohio State University
Target Recruit Count
50
Registration Number
NCT00472524

Evaluating NeuroVision's Neural Vision Correction (NVC) Myopia Treatment

Not Applicable
Terminated
Conditions
Myopia
Interventions
Device: NeuroVision's NVC treatment for Low Myopia
First Posted Date
2007-05-04
Last Posted Date
2018-09-25
Lead Sponsor
Ohio State University
Target Recruit Count
2
Registration Number
NCT00469612
Locations
🇺🇸

College of Optometry, The Ohio State University, Columbus, Ohio, United States

Study to Determine Whether There Are Any Cognitive or Motor Effects From Taking the Medicine Risperidone.

Phase 3
Completed
Conditions
Oppositional Defiant Disorder
Conduct Disorder
Attention Deficit/Hyperactivity Disorder (ADHD)
Impulse-Control Disorders
Intermittent Explosive Disorder
Adjustment Disorder
Bipolar Disorder
Pervasive Developmental Disorder
First Posted Date
2006-11-15
Last Posted Date
2016-06-23
Lead Sponsor
Ohio State University
Target Recruit Count
30
Registration Number
NCT00399698
Locations
🇺🇸

Ohio State University Nisonger Center, Columbus, Ohio, United States

N-acetylcysteine in Intra-amniotic Infection/Inflammation

Phase 1
Completed
Conditions
Chorioamnionitis
Labor, Premature
Inflammation
Preterm Premature Rupture of the Membranes
Infection
Interventions
Procedure: amniocentesis
First Posted Date
2006-11-09
Last Posted Date
2018-10-10
Lead Sponsor
Ohio State University
Target Recruit Count
68
Registration Number
NCT00397735
Locations
🇺🇸

Yale New Haven Hospital, New Haven, Connecticut, United States

🇺🇸

The Research Institute at Nationwide Children's Hospital, Columbus, Ohio, United States

Measurement of Risperidone and 9-Hydroxyrisperidone in Plasma and Saliva

Completed
Conditions
Patients Already Taking Risperidone for Clinical Indications
First Posted Date
2006-11-03
Last Posted Date
2016-06-23
Lead Sponsor
Ohio State University
Target Recruit Count
19
Registration Number
NCT00395499
Locations
🇺🇸

General Clinical Research Center, Columbus, Ohio, United States

🇺🇸

The Nisonger Center, Columbus, Ohio, United States

Fish Oil (Omega 3), Immune Function, and Mood

Phase 2
Completed
Conditions
Inflammation
Interventions
Dietary Supplement: Omega 3 (Fish Oil) Supplementation
Dietary Supplement: Placebo
First Posted Date
2006-10-11
Last Posted Date
2012-11-20
Lead Sponsor
Ohio State University
Target Recruit Count
138
Registration Number
NCT00385723
Locations
🇺🇸

The Ohio State University, Columbus, Ohio, United States

Study of the Relationship Between Blood Vessels and Insulin Response in Adolescents

Completed
Conditions
Stroke
Diabetes Mellitus, Type 2
Hypertension
Heart Disease
First Posted Date
2006-09-11
Last Posted Date
2016-06-08
Lead Sponsor
Ohio State University
Target Recruit Count
66
Registration Number
NCT00374361
Locations
🇺🇸

Ohio State University, Columbus, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath